Digital health technology for the end TB strategy: Developing priority products and making them work Dennis Falzon (Geneva, Switzerland), Dennis Falzon, Giovannibattista Migliori, Ernesto Jaramillo, Mario Raviglione
| |
Side effects of tuberculosis treatment with fixed-dose combinations Insaf Mejri (Tunis, Tunisia), Insaf Mejri, Manel Loukil, Ikbelle Khalfallah, Hedia Ghrairi
| |
Safety and acceptability of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis Aissa Sana (Kairouan, Tunisia), Aissa Sana, Mabrouk Sonia, Abdelghani Ahmed, Benzarti Wafa, Sfaxi Raoudha, Gargouri Imen, Ben Salem Halima, Garrouche Abdelhamid, Hayouni Abdelaziz, Benzarti Mohamed
| |
Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB Mykhailo Kuzhko (Kyiv, Ukraine), Mykhailo Kuzhko, Ljubomyr Procyk, Leonid Grechanyk, Mykola Gumenjuk, Nataliia Hulchuk, Oksana Avramchuk
| |
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity Shih-Lung Cheng (Taipei, Taiwan), Shih-Lung Cheng
| |
Tuberculosis costs in Spain and related factors Jose Maria Garcia Garcia (Candas (Asturias), Spain), Jose Antonio Gullón-Blanco, Juan Rodríguez-López, Manuel-Angel Villanueva Montes, Fernando Alvarez Navascues, Jose Maria Garcia Garcia, Teresa Rodrigo, Martí Casals, Joan Caylá, Grupo de Trabajo PII-TB SEPAR
| |
The costs of MDR/XDR tuberculosis in Barcelona (Spain): Cases treated with DOTs/DOT plus in a specialized centre Maria Altet Gomez (Premia de Dalt, Spain), Maria Altet Gomez, Joan Pau Millet, Jose Maldonado, Israel Molina-Pinargote, Yoel Gonzalez-Diaz, Juana Soteras, Xavier Dominguez
| |
Latent TB infection: Patient choices and completion of treatment Hilary Tedd (Newcastle, United Kingdom), Hilary Tedd, James Macfarlane, Chris Stenton
| |
The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots Marina Safaryan (Yerevan, Armenia), Marina Safaryan, Davit Khalatyan, Lilit Gevorgyan
| |
Vitamin D binding protein (DBP) levels during tuberculosis treatment are affected by DBP genotype / haplotype but not by total vitamin D levels Gemma Hawthorne (Meriden, United Kingdom), Gemma Hawthorne, Martin Dedicoat, David Thickett, Alice Turner
| |
Vitamin D supplementation in health and latent tuberculosis significantly influences T lymphocyte cytokine response Gemma Hawthorne (Meriden, United Kingdom), Gemma Hawthorne, JinJin Zhang, Heinke Kunst, David Thickett, Alice Turner
| |
Correlation between matrix metalloproteinase-9 serum levels and disease severity in pulmonary tuberculosis patients Eliana Muis (Makassar, Indonesia), Eliana Muis, Erwin Arief, Irawaty Djaharuddin
| |
Matrix metalloproteinases (MMPs) and acute phase proteins (APP) in predicting the efficacy of intensive phase treatment (IPP) in patients with pulmonary tuberculosis (PT) Diljara Esmedlyaeva (St.Petersburg, Russian Federation), Diljara Esmedlyaeva, Nina Alexeeva, Larisa Kiryukhina, Maria Pavlova, Viacheslav Zhuravlev, Marina Dyakova
| |
Bioinformatics approach identified of novel genes of tuberculosis susceptibility Elena Bragina (Tomsk, Russian Federation), Elena Bragina, Alexey Rudko, Evgeny Tiys, Nadezhda Babushkina, Vladimir Ivanisenko, Maxim Freidin
| |
Evaluation of pulmonary TB treatment efficiency depending on polymorphism of glutathione-S-transferasexenobiotic biotransformation enzyme and on sensitivity profile Tetiana Sprynsian (Kiev, Ukraine), Tetiana Sprynsian, Lilia Todoriko, Igor Semianiv
| |
Effect of anti-tuberculosis treatment on body composition during the intensive phase Meriem Mjid (Bab Saadoun/Tunis, Tunisia), Meriem Mjid, Sonia Toujani, Ameni Ben Mansour, Abir Hedhli, Houda Snen, Yacine Ouahchi, Nozha Ben Salah, Abdelmajid Ben Hmida, Bechir Louzir, Nadia Mhiri, Jouda Cherif, Majed Beji
| |
Malnutrition in tuberculosis: Value of fat- free mass and creatinine-height index assessment Aliae Mohamed-Hussein (Assiut, Egypt), Aliae A.R. Mohamed-Hussein, Susan Salama, Medhat Khalil, Safaa Eid
| |
Cigarette smoke has a negative impact on M. tuberculosis immune response Maria Altet Gomez (Premia de Dalt, Spain), Maria Altet Gomez, Jose Dominguez, Joan Pau Millet, Jose Maldonado, Maria Louiza de Sosa-Galvao, Angeles Jimenez, Celia Mila, Cristina Prat, Israel Molina-Pinargote, Yoel Gónzalez-Diaz, Irene Latorre
| |
The associations between a smoking and IL-10 gene polymorphism in patients with MDRTB Dmytro Butov (Kharkiv, Ukraine), Dmytro Butov, Mykhailo Kuzhko, Tetyana Butova
| |
Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment? Fatih Yakar (Istanbul, Turkey), Fatih Yakar, Aysun Yakar, Nur Büyükpinarbasili, Mustafa Erelel
| |